Tango Therapeutics Inc (NASDAQ: TNGX) is -2.12% lower on its value in year-to-date trading and has touched a low of $5.15 and a high of $13.03 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNGX stock was last observed hovering at around $9.09 in the last trading session, with the day’s gains setting it 0.6%.
Currently trading at $9.69, the stock is -8.89% and -1.57% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.12 million and changing 6.60% at the moment leaves the stock 3.69% off its SMA200. TNGX registered 17.45% gain for a year compared to 6-month loss of -3.10%.
The stock witnessed a 14.00% gain in the last 1 month and extending the period to 3 months gives it a 40.03%, and is -10.61% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.00% over the week and 7.96% over the month.
Tango Therapeutics Inc (TNGX) has around 140 employees, a market worth around $1.04B and $42.51M in sales. Profit margin for the company is -274.04%. Distance from 52-week low is 88.16% and -25.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.14%).
The EPS is expected to shrink by -22.90% this year
175.0 institutions hold shares in Tango Therapeutics Inc (TNGX), with institutional investors hold 103.95% of the company’s shares. The shares outstanding are 102.20M, and float is at 57.42M with Short Float at 17.62%. Institutions hold 90.52% of the Float.
The top institutional shareholder in the company is TRV GP IV, LLC with over 19.2 million shares valued at $164.75 million. The investor’s holdings represent 17.751 of the TNGX Shares outstanding. As of 2024-06-30, the second largest holder is ECOR1 CAPITAL, LLC with 13.33 million shares valued at $114.38 million to account for 12.3237 of the shares outstanding. The other top investors are FMR LLC which holds 9.41 million shares representing 8.6983 and valued at over $80.73 million, while BOXER CAPITAL, LLC holds 7.5793 of the shares totaling 8.2 million with a market value of $70.34 million.
Tango Therapeutics Inc (TNGX) Insider Activity
The most recent transaction is an insider sale by Third Rock Ventures IV, L.P., the company’s 10% Owner. SEC filings show that Third Rock Ventures IV, L.P. sold 75,000 shares of the company’s common stock on Sep 05 ’24 at a price of $11.56 per share for a total of $0.87 million. Following the sale, the insider now owns 16.93 million shares.
Still, SEC filings show that on Aug 30 ’24, Third Rock Ventures IV, L.P. (10% Owner) disposed off 175,000 shares at an average price of $11.60 for $2.03 million. The insider now directly holds 17,001,475 shares of Tango Therapeutics Inc (TNGX).
